Folate-conjugated gold nanoparticle as a new nanoplatform for targeted cancer therapy

被引:0
作者
Hadi Samadian
Samira Hosseini-Nami
Seyed Kamran Kamrava
Habib Ghaznavi
Ali Shakeri-Zadeh
机构
[1] Tehran University of Medical Sciences (TUMS),Department of Medical Nanotechnology, School of Advanced Technologies in Medicine
[2] Iran University of Medical Sciences (IUMS),Clinical Nanomedicine Laboratory, ENT and Head and Neck Surgery Research Center, Rasoul Akram Hospital
[3] Zahedan University of Medical Sciences (ZaUMS),Medical Physics Department, School of Medicine
[4] Iran University of Medical Sciences (IUMS),Diagnostic Nanoparticles Research Core
[5] Iran University of Medical Sciences (IUMS),undefined
来源
Journal of Cancer Research and Clinical Oncology | 2016年 / 142卷
关键词
Cancer; Nanotechnology; Targeting; Folic acid; Gold nanoparticles;
D O I
暂无
中图分类号
学科分类号
摘要
Conventional cancer treatment methods suffer from many limitations such as non-specificity and low efficacy in discrimination between healthy and cancer cells. Recent developments in nanotechnology have introduced novel and smart therapeutic nanomaterials that basically take advantage of various targeting approaches. Targeted nanomaterials selectively bind to the cancer cells and affect them with minor effects on healthy cells. Folic acid (folate) is an essential molecule in DNA synthesis pathway which is highly needed for cancer cell duplication. Some certain cancer cells overexpress folate receptors higher than normal cells, and this fact is the basis of folate targeting strategy. There are many publications reporting various folate conjugated nanomaterials among which folate-conjugated gold nanoparticles hold great promises in targeted cancer therapy. Gold nanoparticles have been identified as promising candidates for new cancer therapy modalities because of biocompatibility, easy synthesis and functionalization, chemo-physical stability, and optical tunable characteristics. In the last decade, there has been a significant explosion in gold nanoparticles research, with a rapid increase in publications related to the area of biomedicine. Although there are many reports published on “gold nanoparticles” and “folate targeting,” there are a few reports on “folate-conjugated gold nanoparticles” in biomedical literature. This paper intends to review and illustrate the recent advances in biomedicine which have been designed on the basis of folate-conjugated gold nanoparticles.
引用
收藏
页码:2217 / 2229
页数:12
相关论文
共 119 条
[1]  
Asadishad B(2010)Folate-receptor-targeted delivery of doxorubicin using polyethylene glycol-functionalized gold nanoparticles Ind Eng Chem Res 49 1958-1963
[2]  
Vossoughi M(2014)Cancer active targeting by nanoparticles: a comprehensive review of literature J Cancer Res Clin Oncol 141 769-784
[3]  
Alemzadeh I(2014)Cancer active targeting by nanoparticles: a comprehensive review of literature J Cancer Res Clin Oncol 141 769-784
[4]  
Bazak R(1987)Radiosensitization in vitro by cis-diammine (1, 1-cyclobutanedicarboxylato) platinum (II)(carboplatin, JM8) and ethylenediammine-malonatoplatinum (II)(JM40) Radiother Oncol 9 157-165
[5]  
Bazak R(2016)Evaluation of the sonosensitizing properties of nano-graphene oxide in comparison with iron oxide and gold nanoparticles Phys E 81 308-314
[6]  
Begg A(2014)Cancer nanotechnology: the impact of passive and active targeting in the era of modern cancer biology Adv Drug Deliv Rev 66 2-25
[7]  
Beik J(2010)Emerging nanomedicines for early cancer detection and improved treatment: current perspective and future promise Pharmacol Ther 128 324-335
[8]  
Bertrand N(2012)VEGF gene alternative splicing: pro-and anti-angiogenic isoforms in cancer J Cancer Res Clin Oncol 138 363-370
[9]  
Bharali DJ(2002)Nanoparticles in cancer therapy and diagnosis Adv Drug Deliv Rev 54 631-651
[10]  
Mousa SA(2009)Parameters governing gold nanoparticle X-ray radiosensitization of DNA in solution Colloids Surf B 72 128-134